alt Hacker NewsInteresting, biotech stocks have been notoriously hard to predict because their business model revolves around science, and it’s hard to know when the science is right. Depending on the situation, I think sentiment could potentially be a misleading/confounding variable here…
Sentiment is crucial - if you know sentiment is incorrectly oriented, you can capitalize on it. If you know it's correct, you can identify mispricing, and strategize accordingly.